Back
Share
Addition is a New York–based venture capital firm founded by former Tiger Global partner Lee Fixel in 2020. It manages over $7 billion across multiple funds and invests in early- to growth-stage tech companies, allocating about one-third of capital to seed and early rounds while supporting founders with conviction-focused, long-term partnership
Addition
VC firm
Specification
Stages
3. Early Revenue
4. Scaling
5. Growth
Target countries
USA
Lead
Lee Fixel
Tickets
$1M to $50M
Location
65 East 55th Street, 36th Floor, New York, New York, United States
Explore similar Venture Funds to Addition
We invest in B2B or B2B2C software companies with 2M+ ARR in real estate, fintech, insurtech, and home services. We also have a stage agnostic acce...
Specification
Target countries
USA
Stages
4. Scaling
5. Growth
+ 1
Mempool Ventures is an investment and acceleration firm dedicated to empowering visionary founders in reshaping the world through cutting-edge tech...
Specification
Target countries
Afghanistan
Angola
Andorra
Antigua and Barbuda
Argentina
Armenia
Australia
Austria
Azerbaijan
Bahamas
Bahrain
Algeria
Belarus
Barbados
Belgium
Belize
Benin
Bhutan
Botswana
Bosnia-H
Brunei
Brazil
Burkina Faso
Bulgaria
Cabo Verde
Cambodia
Cameroon
Burundi
Bangladesh
Canada
Chile
Colombia
Comoros
Congo (Congo-Brazzaville)
Chad
Albania
Central African Republic
Costa Rica
Côte d'Ivoire
Croatia
Cyprus
Czech Republic
DRC Congo
Denmark
Djibouti
Dominica
Dominican Republic
Ecuador
Equatorial Guinea
El Salvador
Eritrea
Estonia
Eswatini (fmr. "Swaziland")
Fiji
Finland
Ethiopia
France
Gambia
Gabon
Germany
Georgia
Ghana
Greece
Grenada
Guatemala
Cuba
Iceland
Ireland
Israel
Italy
Jamaica
Japan
Monaco
New Zealand
Netherlands
Philippines
Spain
Saudi Arabia
USA
UK
UAE
Norway
Switzerland
Singapore
Sweden
Hong Kong
Latvia
Lithuania
Stages
1. Idea or Patent
Bullpen Capital is a venture capital firm focused on post-seed investments for early-stage companies that have achieved product-market fit but are ...
Specification
Target countries
USA
Stages
3. Early Revenue
We invest in Deep tech as such, anything which has ideally R&D behind its products and solutions: Quantum, Nanotechnology, AI, hardware, chips...
Specification
Target countries
Czech Republic
Germany
Poland
Slovakia
UK
USA
Israel
Spain
Austria
Stages
2. Prototype
3. Early Revenue
+ 1
We invest in tomorrow’s financial technology themes. We look at B2B, B2B2C, vertically integrated payments, Banking-as-a-Service, BaaS, embed...
Specification
Target countries
UK
Denmark
Sweden
Germany
France
Spain
Netherlands
Norway
Poland
Austria
Croatia
Switzerland
Portugal
Italy
Greece
Czech Republic
Stages
3. Early Revenue
4. Scaling
OrbiMed is a leading global healthcare investment firm focused on driving innovation in biopharmaceuticals, medical devices, diagnostics, and healt...
Specification
Target countries
Canada
USA
India
Israel
China
UK
Stages
3. Early Revenue